Litigation Details for Mayo Clinic v. Celgene Corporation (N.D. Cal. 2023)
✉ Email this page to a colleague
Mayo Clinic v. Celgene Corporation (N.D. Cal. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-10-06 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | |
Jury Demand | Plaintiff | Referred To | |
Parties | NATCO PHARMA LIMITED | ||
Patents | 6,315,720; 6,561,977; 6,755,784; 6,869,399; 7,141,018; 7,189,740; 7,230,012; 7,465,800; 7,468,363; 7,855,217; 7,959,566; 7,968,569; 8,288,415; 8,315,886; 8,404,717; 8,492,406; 8,530,498; 8,626,531; 8,648,095; 8,741,929; 9,056,120; 9,101,621; 9,101,622; 9,155,730; 9,393,238 | ||
Attorneys | Melissa A. Meister | ||
Firms | Brs LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Mayo Clinic v. Celgene Corporation
Biologic Drugs cited in Mayo Clinic v. Celgene Corporation
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Mayo Clinic v. Celgene Corporation (N.D. Cal. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-10-06 | 1 | Complaint | 8,589,188 (the “’188 Patent”); 6,315,720 (the “’720 Patent”); 6,561,977 (the “’977 Patent”); 22 6,755,784 (the… to the drug ’720 6,315,720 23-Oct-00 13-Nov- 23-Oct-20 Methods… ’517 Patent, ’720 Patent, ’977 Patent, ’784 Patent, ’740 Patent, ’800 Patent, 4 ’217 Patent, ’569 …569 Patent, ’886 Patent, ’717 Patent, ’498 Patent, ’531 Patent, ’095 Patent, ’120 5 Patent, ’621 Patent…infringe the ’800 Patent, ’217 Patent, ’569 Patent, ’498 Patent, ’095 Patent, ’621 Patent, 22 23 24 195 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |